Korro Bio, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2a, Single- and Multiple-dose Escalation Study of KRRO-110 (NCT06677307) | Korro Bio, Inc. | 2025-01-13 |
Track Korro Bio, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.